RPRX

Repros Therapeutics Inc.
RPRX

Overview Fund Activity
Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

46 hedge funds and large institutions have $14.5M invested in Repros Therapeutics Inc. in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.

Holders
46
Holders Change
+3
Holders Change %
+6.98%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
10
Closed
5
Calls
$1.54M
Puts
$150K
Net Calls
+$1.39M
Net Calls Change
+$458K

Top Buyers

1
SFM
1
Sphera Funds Management
Israel
$1.81M
2
GAI
2
General American Investors
New York
$1.49M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.39M
4
VKH
4
Virtu KCG Holdings
New York
$54K
5
Wolverine Trading
5
Wolverine Trading
Illinois
$40K

Top Sellers

1
AIM
1
Alambic Investment Management
California
$0
2
BIM
2
Bogle Investment Management
Massachusetts
$96K
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$560K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.01M
5
ARTA
5
A.R.T. Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
51
Citadel Advisors
Florida
– – – –
CG
52
Cutler Group
California
$0 47 – –
Susquehanna International Group
53
Susquehanna International Group
Pennsylvania
– – – –
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$0 175 +175 New
1 2
3